These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4590707)

  • 1. Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.
    Loos M; Bitter-Suermann D; Dierich M
    J Immunol; 1974 Mar; 112(3):935-40. PubMed ID: 4590707
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of anti-HL-A alloantisera by glycoproteins, polysaccharides, and lipopolysaccharides from diverse sources.
    Mittal KK; Terasaki PI; Springer GF; Desai PR; McIntire FC; Hirata AA
    Transplant Proc; 1973 Mar; 5(1):499-506. PubMed ID: 4572110
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
    Morrison DC; Kline LF
    J Immunol; 1977 Jan; 118(1):362-8. PubMed ID: 318670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.
    Galanos C; Lüderitz O; Westphal O
    Eur J Biochem; 1971 Dec; 24(1):116-22. PubMed ID: 4944989
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of C1 in the complement activating effect of Pseudomonas aeruginosa lipopolysaccharide preparations.
    Füst G; Adám MM
    Acta Microbiol Acad Sci Hung; 1976; 23(3):239-49. PubMed ID: 828439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The interaction of antibody and complement with model membranes (author's transl)].
    Inoue K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):741-54. PubMed ID: 4612613
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic determinant of Salmonella lipopolysaccharide participating in the hypersensitivity of infected mice.
    Kawakami M; Hara Y; Mitsuhashi S
    Jpn J Med Sci Biol; 1973 Feb; 26(1):18-22. PubMed ID: 4124713
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the classic and alternate complement pathways by endotoxin.
    Fine DP
    J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.
    Westphal O; Jann K; Himmelspach K
    Prog Allergy; 1983; 33():9-39. PubMed ID: 6187018
    [No Abstract]   [Full Text] [Related]  

  • 10. Host defense against bacterial endotoxemia-contribution of the early and late components of complement to detoxification.
    May JE; Kane MA; Frank MM
    J Immunol; 1972 Oct; 109(4):893-5. PubMed ID: 4561474
    [No Abstract]   [Full Text] [Related]  

  • 11. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
    Kozlov LV; Zinchenko AA; Soliakov LS; Sizoĭ MN; Ishchenko AM
    Bioorg Khim; 1983 Aug; 9(8):1047-55. PubMed ID: 6680304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune damage to a lipid model membrane.
    Kinsky SC
    Ann N Y Acad Sci; 1972 Jun; 195():429-38. PubMed ID: 4338422
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent findings on the chemical structure and biological activity of bacterial lipopolysaccharides.
    Lüderitz O; Galanos C; Lehmann V; Rietschel ET
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(4):381-90. PubMed ID: 4141712
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system.
    Bitter-Suermann D; Hadding U; Schorlemmer HU; Limbert M; Dierich M; Dukor P
    J Immunol; 1975 Aug; 115(2):425-30. PubMed ID: 239062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite complement: a mixture of feline C1 and guinea pig complement as a reagent compatible with feline antibodies.
    Olsen RG; Krakowka SG; Mathes LE; Yohn DS
    Am J Vet Res; 1974 Nov; 35(11):1389-92. PubMed ID: 4139913
    [No Abstract]   [Full Text] [Related]  

  • 17. IMMUNOLOGICAL CHARACTERIZATION OF ANTIGENIC EXTRACTS OBTAINED FROM BACTERIA WITH DIFFERENT METHODS. I. MICROORGANISMS OF THE GENERA SALMONELLA AND ESCHERICHIA.
    TRUSZCZYNSKI M
    Arch Immunol Ther Exp (Warsz); 1963; 11():247-71. PubMed ID: 14062973
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological activities of lipid A complexed with bovine-serum albumin.
    Galanos C; Rietschel ET; Lüderitz O; Westphal O; Kim YB; Watson DW
    Eur J Biochem; 1972 Dec; 31(2):230-3. PubMed ID: 4567119
    [No Abstract]   [Full Text] [Related]  

  • 19. Salmonella O antigens and virulence.
    Roantree RJ
    Annu Rev Microbiol; 1967; 21():443-66. PubMed ID: 4860265
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.